الفهرس 
Introducation and Aim of the workOnly 14 pages are availabe for public view
 |  | from | 150 |  |  |
| | | from | 150 | | |
Abstract
Women may present with concerns about sexual function associated with their method of the chosen contraception, particularly hormonal contraception.
Aim of the work: to study the female sexual function in a group of women, at reproductive age, using common methods of contraception.
Patients and methods:
This cross sectional controlled research was designed to study the effect of the commonly used contraceptive methods on the female sexual functions. The study was designed to include 2 groups of apparently healthy women: group 1 (107 women using hormonal contraception or intrauterine device) and group 2 (100 women control group) not using any contraceptive method. All included participants answered the 19- item Arabic translation of Female Sexual Function Index (FSFI) questionnaire (Anis et al., 2011).
Results:
In this study, IUD user represented the highest percentage (42%) followed by oral tablets users (37.4%)Microcept users (19.6%) Levenor users(17.8%) and the least used Depoprovira injection that represented (20.6%( In this study, neither IUDs nor the oral tablets, micorcept (combined oestrogen and progesterone) had a negative impact on the female sexual function. Compared to controls, in women used IUDs, the satisfaction score was significantly higher (P values: 0.017) but all other sex domains’s scores and total score had insignificant differences. In women used the oral contraceptive microcept, all individual sex domains’ scores and the total score had insignificant differences compared to controls. On the contrary to IUD and microcept users, women used Depoprovera injection, all the sex domains’ domains’ scores, excluding the pain domain score, and the total score were significantly lower compared to controls (all P values: ˂0.001). In women used the oral contraceptive Levonor, desire, arousal, lubrication, orgasm domains’ scores and the total score were significantly lower compared to controls (P values: ˂0.001 ˂0.001, 0.045, 0.43 and 0.003 Respectively).
Conclusion
In this study, IUD user represented the highest percentage (42%) followed by oral tablets users (37.4%) and the least used Depoprovira injection that represented 20.6%. Neither IUDs nor the oral tablets, micorcept (combined oestrogen and progesterone) had a negative impact on the female sexual function. Using pills or injectable containing progestin only had a negative impact on FSF; Depoprovira injection had the worst impact, of all used contraceptive methods, on FSF.
Recommendation:
Healthcare providers need to openly query women about FSD, evaluate sexual function concerns, and consider alternative contraceptive options when needed.
In family planning programs, use of contraceptive methods that were more effective and had less sexual function impairment should be recommended.
Awareness’ campaigns about different contraception methods and their impact on female sexual function should be conducted.